Despite higher earnings, Wall St. wary of healthcare

While many of the largest healthcare companies have seen rising revenues and record profits at the start of 2019, stock prices aren’t reflecting their successes, Axios reported.

The discrepancy underscores that investors are wary about the healthcare sector as the Affordable Care Act is under dispute in court and as some lawmakers continue to push for a single-payer healthcare system. In fact, the rising support for Medicare for all may have soured healthcare on Wall St., according to Axios.

Another major factor in the space is the ongoing debate around rebates, which the Trump administration has considered eliminating from pharmacy benefit managers. That uncertainty has created further turmoil across healthcare stocks.

See the full story below: